Faster clearance of dying cells spreads live pathogens to new host cells
The hypothesis says that clearing dying cells faster can spread infection through membrane-enclosed cargo. Making that cargo noninfectious while preserving its uptake would remove the harm; treatment timing would depend on infectious cargo availability, not just the body's internal clock.
Omega Point 1.2
Stage of verification
- Hypothesis published2026-09-20
- Indirect evidenceAssessed at 5 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Immune response
Cargo-mediated pathogen transfer
Transfer of viable pathogens enclosed in dying cells or membrane fragments into recipient host cells
Where this hypothesis actsDuring accelerated resolution when shifted sleep and feeding increase overlap between infectious cargo and engulfment
Hypotheses on this target 1
Inhibition
Activation
Function preservation
Clearance restoration
Immunosuppression
Feedback restoration
Rhythm restoration
What is proposed
Prevent productive pathogen transfer while preserving cargo recognition and uptake
With whatNot stated in the record
HowRender cargo noninfectious while preserving its membrane recognition and uptake; the means of inactivation is not stated
Possible result
Expected removal of the excess dissemination caused by accelerated resolution
From the recordRendering cargo noninfectious while preserving its membrane recognition and uptake will remove the adverse effect of accelerated resolution.
Immune response
Efferocytosis
The engulfment and clearance of apoptotic cells by phagocytes
Where this hypothesis actsAt graft interfaces under shifted sleep and feeding schedules, after viable infectious cargo has been eliminated
Hypotheses on this target 9- Inhibition5
- Activation2
- Function preservation
- Clearance restoration1
- Immunosuppression
- Feedback restoration
- Rhythm restoration
What is proposed
Activation
Enhance engulfment only after viable infectious cargo has been eliminated
With whatNot stated in the record
HowTime enhanced resolution to the elimination of viable cargo rather than host-clock phase alone; no specific intervention is stated
Possible result
Possible reduction in local inflammation and interface injury without increased pathogen transfer
From the recordPhase-targeted resolution therefore helps only when delivered after viable cargo has been eliminated; host-clock phase alone cannot guarantee safety.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Replacing worn tissue may require preserving infection defenses while the replacement settles into its surroundings. The unexpected move is that clearing dying cells could give the pathogens inside them a route into fresh cells, even as local inflammation falls. This is a proposal generated by the pipeline, not a measured result about tissue replacement or lifespan.
- Dying cells or their membrane fragments enclose pathogens that remain capable of infection.
- Accelerated clearance increases engulfment of this infectious cargo by cells that can support the pathogen.
- Engulfed pathogens establish new infections inside recipient cells instead of being destroyed during disposal.
- Local inflammation and injury decline while successful transfers of infection increase.
- Shifted sleep and feeding schedules increase the overlap between infectious cargo being available and enhanced engulfment.
- Treatment timed to aid resolution avoids this proposed route of spread only after infectious cargo has been eliminated; a particular daily clock time alone is insufficient.
A cleanup crew moves sealed bags out of damaged rooms, but some bags contain live pests that escape in the rooms receiving them. Faster cleanup can leave the original rooms looking better while spreading the infestation.
Where the picture breaks: Engulfing cells can destroy what they collect, and pathogens differ in their ability to survive and infect those cells. The picture does not establish that speeding clearance increases infection or that daily schedules determine transfer.
- Master questionstep 01 of 04
The aim is to identify the smallest amount of tissue, and the specific cells or structures, that would need replacing to slow aging and extend life.
Rests on: The stated goal is to determine whether selective replacement can deliver those benefits and what would need replacing.
Stated in the chain - Goal pillarstep 02 of 04
Tissue repair is framed as potentially conflicting with protective surveillance, meaning the detection and control of threats, while repeated injury must be contained.
Rests on: Successful replacement is taken to depend on managing a conflict between repair and protection.
AssumptionThe master question does not establish that this conflict determines the amount or location of tissue that must be replaced; the pillar takes its relevance as given.
- Gap questionstep 03 of 04
Faster resolution, the winding down of inflammation, at the boundary of a graft, or transplanted tissue, might prolong vulnerability to infection when sleep and feeding schedules shift. Treatment timed to particular parts of a daily cycle is proposed for comparison with continuous suppression of inflammation.
Rests on: The preceding pillar supplies a general repair–protection conflict, but not the specific connection to daily schedules or the boundary around transplanted tissue.
LeapNeither the preceding text nor the supplied sources establishes that shifted sleep and feeding make faster resolution at a graft boundary prolong infection vulnerability, or that timed treatment preserves both infection control and graft function.
- Hypothesisstep 04 of 04
Faster efferocytosis, the engulfment and removal of dying cells, is proposed to pass live pathogens, or infection-causing organisms, into fresh host cells inside membrane-enclosed cargo. Inflammation could fall while infection spreads, making treatment safety depend on whether infectious cargo remains rather than on the body's daily clock alone.S2S5
Rests on: The previous question supplies the proposed repair–infection tradeoff. Nature (2014), S5, supports engulfment-related spread of Listeria bacteria in mouse immune-cell cultures and mice; it does not establish that faster clearance increases spread or that treatment timing controls safety. Proceedings of the National Academy of Sciences of the United States of America (2023), S2, supports African swine fever virus transfer through dying-cell fragments between pig immune cells; it does not establish the proposed acceleration, graft effects or schedule dependence.
Supported by literature
What is carried, and what is not. The supplied sources speak to two component links: dying-cell clearance can accompany reduced inflammation, and infectious material can spread through engulfment. The Journal of Experimental Medicine (2023), S1, supports the first in an injury setting without establishing infectious transfer; S2 and S5 support the second in the specific pig-virus and mouse-bacterium systems described above, but nothing supplied establishes the full sequence from accelerated clearance through shifted schedules to graft safety.S1S2S5
Where the reasoning is carried by something unstated · 2
- Goal pillar. The master question does not establish that this conflict determines the amount or location of tissue that must be replaced; the pillar takes its relevance as given.
- Gap question. Neither the preceding text nor the supplied sources establishes that shifted sleep and feeding make faster resolution at a graft boundary prolong infection vulnerability, or that timed treatment preserves both infection control and graft function. Establish the missing link before relying on this step.
How a result here could mislead · 3
- Finding both membrane material and a live pathogen inside a recipient cell could be mistaken for a newly established infection, although it might show only uptake of material awaiting destruction. What closes it: The proposed separate labels for host membranes and pathogen viability must be accompanied by evidence that transferred pathogens establish infection in recipient cells. Uptake and successful infection must be measured separately.
- Making cargo noninfectious could reduce spread by changing how much cargo is recognized or engulfed, falsely attributing the benefit specifically to loss of infectious contents. What closes it: The comparison must verify preserved membrane recognition and uptake, as the prediction requires, while matching the starting amount of pathogen. It must also verify matched immune-cell destinations and survival of neutrophils, infection-fighting white blood cells, to distinguish the two rival explanations.
- Moving the apparent best treatment time could be credited to changed cargo availability even if the manipulation also shifts the body's daily clock or changes how much infectious cargo is present. What closes it: The timing comparison must measure infectious cargo availability and the body's daily clock independently, establish that the clock remains unchanged, and distinguish a timing shift from a change in cargo amount.
What would make this wrong. The proposed explanation fails if accelerated clearance worsens infection without successful transfer from engulfed infectious cargo into newly infected recipient cells. It also fails its distinguishing prediction if making the cargo noninfectious leaves the excess spread intact despite preserved recognition and uptake and matched starting pathogen amount, immune-cell destinations and neutrophil survival.
What it would change. If this held, replacement strategies would need to judge healing alongside whether dying-cell material can still transmit infection; reduced inflammation alone would not establish that the replacement is safe. Treatment timing would have to account for infectious cargo rather than relying only on the body's daily clock. Even a successful initial test would not identify the minimum tissue replacement needed, establish the mechanism in aged grafts, or show slower aging or longer life.
Sources read · 9
Trained immunity of alveolar macrophages enhances injury resolution via KLF4-MERTK-mediated efferocytosis. · The Journal of experimental medicine · 2023
“Thus, the present study demonstrates that preferential release of anti-inflammatory cytokines and increased efferocytosis after injury are hallmarks of trained immunity that facilitate injury resolution.”
Does not settle: This source does not establish that efferocytosis transfers viable pathogens or infectious membrane-enclosed cargo to permissive host cells, increases intracellular infection spread, or that timing resolution by host-clock phase affects such transfer.
Riding apoptotic bodies for cell-cell transmission by African swine fever virus. · Proceedings of the National Academy of Sciences of the United States of America · 2023
“The PS-positive ApoBDs carrying single-membrane virions are then phagocytosed by neighboring PAMs via PS interaction with efferocytosis receptors (e.g., TIM4, MFG-E8, etc.).”
Does not settle: This source supports uptake-mediated ASFV transfer between pig macrophages via apoptotic bodies, but does not establish that accelerated efferocytosis generally increases pathogen spread, that inflammation or interface injury decline, or that schedule shifts, resolution timing, host-clock phase, or SPV_10 are affected.
Apoptotic cell identity induces distinct functional responses to IL-4 in efferocytic macrophages. · Science (New York, N.Y.) · 2024
“Knockout of phagocytic receptors required for the uptake of apoptotic neutrophils and partially T cells, but not hepatocytes, exacerbated helminth infection.”
Does not settle: This abstract describes apoptotic-cell identity and IL-4-driven macrophage responses in a mouse helminth model. It does not establish that accelerated efferocytosis transfers viable pathogens from dying cargo to permissive host cells, increases intracellular infection dissemination, or that timing relative to pathogen elimination determines safety.
PI3KC3 complex subunit NRBF2 is required for apoptotic cell clearance to restrict intestinal inflammation. · Autophagy · 2021
“NRBF2 is required for the clearance of apoptotic cells and alleviation of inflammation during colitis in mice.”
Does not settle: It does not assess pathogens, viable infectious cargo, infection transfer to new host cells, timing or schedule effects, or uptake-mediated amplification.
Listeria monocytogenes exploits efferocytosis to promote cell-to-cell spread. · Nature · 2014
“Blocking antibodies that targeted either TIM-4 or PS impaired bacterial spread in cultures of control but not TIM-4 −/− BMDM ( ), indicating that TIM-4 promotes bacterial cell-to-cell spread through its ability to bind PS + structures.”
Does not settle: This source does not establish that faster clearance of dying cells increases transfer, that inflammation or interface injury declines, or that shifted schedules, host-clock phase, or phase-targeted resolution determine safety. It studies L. monocytogenes in mouse macrophage cultures and mice, not a general pathogen-transfer mechanism or SPV_10.
A Nanococktail Strategy Regulating Circadian Clock and Re-Establishing Bone-Immune Balance for the Treatment of Senile Osteoporosis. · ACS nano · 2026
“Circadian rhythm disorders impair the efferocytosis function of macrophages, leading to compensatory nonprofessional efferocytosis by bone mesenchymal stem cells (BMSCs).”
Does not settle: It does not address pathogens, viable infectious cargo, infection transfer to new host cells, clearance timing, or whether enhanced efferocytosis increases intracellular infection spread.
“There is still no evidence of whether the efferocytosis activity of alveolar macrophages is circadian regulated.”
Does not settle: Whether enhanced efferocytosis transfers viable membrane-enclosed pathogens to permissive host cells, increases intracellular infection transfers, or depends on pathogen-elimination timing; it also does not establish the proposed schedule overlap or SPV_10 effect.
Phagocytic aberrations in macrophages in asthma: a mechanistic systematic review integrating in vitro, animal, and human evidence. · Frontiers in immunology · 2026
“This finding suggests that enhanced phagocytic function does not necessarily equate to inflammation resolution; the biological consequences depend on the nature of the engulfed substrate and the subsequent immune programs activated.”
Does not settle: This source text does not establish uptake-mediated transfer of viable pathogens to new host cells, changes in intracellular infection transfer frequency, timing or circadian scheduling effects, or conditions under which resolution-targeted treatment is safe.
Apoptosis and Clearance of Apoptotic Cells. · Annual review of immunology · 2018
“Dead cells generated by apoptosis are quickly engulfed by macrophages for degradation.”
Does not settle: This abstract does not establish whether viable pathogens in dying cells or membrane fragments transfer to new permissive host cells through efferocytosis, whether accelerated engulfment increases intracellular infection transfers, or any timing, schedule, phase-targeting, or SPV_10 effects.
The gap this hypothesis explains
After sleep and feeding shifts, does faster healing prolong infection vulnerability, and does timed treatment protect transplants better than continuous suppression?
Original wording · exactly as the pipeline generated it
Does accelerating interface resolution prolong antimicrobial vulnerability when sleep and feeding shift, and can phase-targeted resolution preserve both pathogen containment and graft function better than continuous suppression?
What this question is asking
The question concerns whether speeding the end of inflammation where transplanted tissue meets surrounding tissue leaves infection defenses weakened for longer when sleep and eating schedules change. That is a possible meaning of “interface resolution,” but the supplied input does not specify the tissue boundary or treatment. It also asks whether treatment timed to a particular part of the body's daily cycle preserves both control of infection and transplant function better than continuously suppressing inflammation. The comparison would need to establish how long infection vulnerability lasts and how well the transplanted tissue works under those approaches. The broader motivation is tissue replacement to slow aging and extend life, but the supplied sources do not connect this treatment comparison to those outcomes.
- Interface resolution
- An unspecified phrase in the question, plausibly referring to the ending of inflammation at a boundary between transplanted and surrounding tissue. The supplied input does not identify that boundary or define how resolution would be measured.
- Inflammation and resolution
- Inflammation is a tissue response involving immune activity during injury or infection. Resolution means the processes that bring that response toward an end; it is not automatically equivalent to complete healing or suppression of all immune defenses.
- Antimicrobial vulnerability
- Susceptibility to infection because defenses against infectious organisms are insufficient. Here the question concerns how long that susceptibility lasts, but no measurement or threshold is supplied.
- Pathogen containment
- Keeping a disease-causing organism under control, such as limiting its growth or spread. The input does not specify which measure of control would count.
- Graft and graft function
- A graft is transplanted tissue. Graft function means how well it performs its intended work, which depends on the tissue involved.
- Circadian rhythms and daily rhythmicity
- Circadian rhythms are biological cycles lasting approximately a day. Daily rhythmicity describes a pattern that varies over the day; loss of that pattern does not by itself establish that a function is continuously weaker.
- Phase-targeted resolution
- Treatment intended to promote the end of inflammation at a selected point in a biological cycle. The question suggests a daily timing reference but does not specify one.
- Continuous suppression
- Ongoing reduction of an activity, apparently inflammation or immune activity in this question. The target, treatment, and degree of reduction are not supplied.
- Immediate and learned immune defenses
- Immediate, or innate, defenses respond without requiring prior learning about a particular infection. Learned, or adaptive, defenses develop more specific responses; these labels describe interacting parts of immunity.
- Ticks
- Small animals with jointed legs that feed on blood. S2 studies their immune cells, so its feeding-related observation does not establish effects of human eating schedules.
- Gene activity
- The extent to which cells use information in particular genes. S6 describes changes in this activity across cell groups, which is different from demonstrating a treatment's effect on transplant function.
- Monocytes and bone marrow
- Monocytes are a type of immune cell, and bone marrow is the tissue inside bones where blood cells are produced. S8 includes their movement from marrow into blood among responses whose daily patterns change with aging.
- Macrophages
- Immune cells that engulf material and participate in infection defense and the control of inflammation. Those functions can vary with cell state; the name does not imply a single repair-only role.
- Neutrophils
- Immune cells involved in responses to infection. S10 concerns living neutrophils trapped inside macrophages, a particular situation rather than a general description of their behavior.
- Pathways
- Linked molecular activities through which cells carry out or regulate a process. The pathways described in S10 concern ending inflammation; their impaired activation does not itself establish an outcome for timed treatment.
- Longer vulnerability; timed treatment protects both outcomes better Under this outcome, accelerating the end of inflammation after schedule changes would lengthen the period of weakened infection defense. A timing-dependent advantage would mean that when treatment occurs helps preserve both infection control and transplant function compared with continuous suppression.
- Longer vulnerability; timed treatment offers no combined advantage Under this outcome, faster resolution would carry an infection-defense cost after schedule changes. Timing treatment would not establish a way to preserve both infection control and transplant function better than continuous suppression.
- No longer vulnerability; timed treatment protects both outcomes better Under this outcome, faster resolution would not lengthen infection vulnerability in the tested setting. Timed treatment could still outperform continuous suppression, but that advantage would not demonstrate that it corrected the proposed prolongation of vulnerability.
- No longer vulnerability; timed treatment offers no combined advantage Under this outcome, the proposed prolongation of infection vulnerability would not be observed. The comparison would also provide no basis for claiming that timed treatment better preserves both infection control and transplant function.
The question links the timing of inflammation control to two outcomes: containing infection and maintaining transplanted tissue. If accelerating the end of inflammation also weakens infection control, tissue recovery could come with a longer period of vulnerability. If timing treatment preserves infection control while allowing recovery, its consequences could differ from those of continuous suppression. These are conditional consequences of the question, not findings established by the supplied sources. Assuming either outcome without evidence could misrepresent whether a treatment protects both functions.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Accelerated efferocytosis creates vulnerability because viable pathogens enclosed in dying cells or membrane fragments gain access to new permissive host cells through the resolution machinery. Local inflammation and interface injury decline while the number of successful intracellular infection transfers increases. Shifted schedules increase overlap between infected-cargo availability and enhanced engulfment. Phase-targeted resolution therefore helps only when delivered after viable cargo has been eliminated; host-clock phase alone cannot guarantee safety. The propagating substrate is infectious membrane-enclosed cargo, and preventing its uptake-mediated amplification would stabilize SPV_10.
What a later run added
A later run reached the same claim about the same subject. Its version was withdrawn in favour of this earlier one, and what it added is kept here, quoted exactly.
Repeated injuries supply successive infected apoptotic carriers, maintaining infection and secondary graft inflammation.
Adds repeated injury as a mechanism that replenishes infectious carriers and sustains the resulting infection.
Viral DNA retained in apoptotic material reaches recipient nuclei and becomes replication competent in permissive recipient cells.
Adds nuclear delivery and restoration of replication competence as the mechanism by which corpse-associated viral genetic material initiates infection.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
At matched initial pathogen burden, leukocyte destination choice and viable-neutrophil survival, excess dissemination will be preceded by viable pathogen transfer from engulfed cargo into recipient phagocytes. Rendering cargo noninfectious while preserving its membrane recognition and uptake will remove the adverse effect of accelerated resolution. Correcting chemotactic ranking or protecting uninfected viable neutrophils will not remove that transfer-dependent excess. The apparent optimal treatment phase will move when infected-cargo availability is shifted without shifting the host clock. Absence of productive cargo-mediated transfer rejects this mechanism even if infection still worsens.
Would tell it apart from at least one rival. The prediction specifies observable temporal ordering, intervention-dependent outcomes, a treatment-phase shift, and an explicit rejection condition. No rival prediction is supplied. A paper already fetched for this hypothesis bears on it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Dual labeling of host membranes and pathogen viability can distinguish uptake from productive infection. Established efferocytosis-linked infection systems permit an initial mechanistic test before aged graft validation. Listeria experiments demonstrated phosphatidylserine-exposing infectious vesicles, TIM-4-dependent spread and impaired bacterial growth in Timd4-deficient mice. This anchors the transfer mechanism, not its proposed circadian coupling. [Czuczman et al., 2014](https://www.nature.com/articles/nature13168).
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
At matched initial pathogen burden, leukocyte destination choice and viable-neutrophil survival, excess dissemination will be preceded by viable pathogen transfer from engulfed cargo into recipient phagocytes. Rendering cargo noninfectious while preserving its membrane recognition and uptake will remove the adverse effect of accelerated resolution. Correcting chemotactic ranking or protecting uninfected viable neutrophils will not remove that transfer-dependent excess. The apparent optimal treatment phase will move when infected-cargo availability is shifted without shifting the host clock. Absence of productive cargo-mediated transfer rejects this mechanism even if infection still worsens.
- Rival 01 of 02What would separate them
Accelerated inflammation resolution removes living defenders and weakens infection control predicts: During the vulnerable internal phase, neutrophils with demonstrable bacterial killing immediately before macrophage contact will undergo engulfment before irreversible death. Matched cells protected from contact will remain viable and continue killing. Selectively protecting viable neutrophils from engulfment, while preserving apoptotic-corpse clearance, will abolish the excess dissemination caused by resolution acceleration without forfeiting its graft-protective effect. Merely redirecting neutrophil migration will not rescue containment once these cells reach the interface and are removed. Finding that engulfed neutrophils were already irreversibly dying, or that viable-cell protection fails despite verified target engagement, would reject this mechanism.
- What would separate them
Resolution redirects living neutrophils toward sterile tissue signals predicts: Neutrophils isolated at the vulnerable phase will respond normally to either sterile or microbial cues presented alone but choose the sterile source when the same cues compete. Independently measured signaling weights will predict a crossover in destination as the cue ratio changes. Selectively reducing the dominant sterile cue or correcting its receptor weighting will restore containment without changing neutrophil survival, efferocytosis or per-cell bacterial killing. A generalized defect in isolated-cue responses, absence of a competitive ranking change, or failure of cue correction despite restored directionality would reject this explanation.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
0 of 1 cited studies could be located, and 0 of 0 figures are not carried by one that resolved.
What it would take to refute it. 7 paper(s) already retrieved for this hypothesis carry its prediction’s terms. Reading them comes before running anything. Already retrieved: Atherosclerotic Cardiovascular Disease and Cancer.; Tissue-Resident Macrophage in Inflammation and Cancer.; The cell with many faces: lung macrophage plasticity and function in response to environmental and pathogenic insults..
6 papers retrieved around this hypothesis
- Atherosclerotic Cardiovascular Disease and Cancer.PMID 42438017 · full_text · 138,740 characters stored
- Spatial architecture of atherosclerotic plaques: coordinating immune responses through mechanotransduction and vesicular trafficking.PMID 42609415 · full_text · 184,920 characters stored
- Tissue-Resident Macrophage in Inflammation and Cancer.PMID 42732341 · full_text · 379,842 characters stored
- DADA2 as a Model of Monogenic Immune Vasculopathy: From Immunopathogenesis to Precision Therapeutics.PMID 42509849 · full_text · 91,735 characters stored
- The cell with many faces: lung macrophage plasticity and function in response to environmental and pathogenic insults.PMID 41921044 · full_text · 329,444 characters stored
- The cell with many faces: lung macrophage plasticity and function in response to environmental and pathogenic insults.PMID 41921044 · full_text · 331,126 characters stored
1 citation handle extracted; 3 Europe PMC searches run; 64 records examined; 5 sources stored for enrichment, 5 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.